Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/50560
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Romagnoli, Romeo | en_US |
dc.contributor.author | Baraldi, Pier Giovanni | en_US |
dc.contributor.author | Cruz-Lopez, Olga | en_US |
dc.contributor.author | Preti, Delia | en_US |
dc.contributor.author | Bermejo, Jaime | en_US |
dc.contributor.author | Estévez, Francisco | en_US |
dc.contributor.other | Baraldi, Pier Giovanni | - |
dc.contributor.other | Romagnoli, Romeo | - |
dc.contributor.other | Estevez, Francisco | - |
dc.contributor.other | preti, delia | - |
dc.contributor.other | Cruz-Lopez, Olga | - |
dc.date.accessioned | 2018-11-24T17:00:04Z | - |
dc.date.available | 2018-11-24T17:00:04Z | - |
dc.date.issued | 2009 | en_US |
dc.identifier.issn | 1860-7179 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/50560 | - |
dc.description.abstract | A novel series of α-bromoacryloyl N-substituted isatin analogues were found to inhibit the growth and viability of human myeloid leukemia HL-60 and U-937 cells as well as human lymphoid leukemia MOLT-3 cells. These compounds show antiproliferative activity which may be mediated by apoptosis caused by cytochrome c release and caspase activation in human leukemia cells. | en_US |
dc.language | eng | en_US |
dc.relation | Desarrollo de Nuevos, Mas Seguros y Mas Efectivos Compuestos Antileucemicos | en_US |
dc.relation.ispartof | ChemMedChem | en_US |
dc.source | Chemmedchem[ISSN 1860-7179],v. 4 (10), p. 1668-1676 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320713 Oncología | en_US |
dc.subject.other | Poly(Adp-Ribose) Polymerase | en_US |
dc.subject.other | Anticancer Drugs | en_US |
dc.subject.other | Cancer Cells | en_US |
dc.subject.other | Death | en_US |
dc.subject.other | Caspases | en_US |
dc.subject.other | Agents | en_US |
dc.subject.other | Cytotoxicity | en_US |
dc.subject.other | Inhibition | en_US |
dc.subject.other | Mechanisms | en_US |
dc.subject.other | Discovery | en_US |
dc.title | alpha-Bromoacrylamido N-Substituted Isatin Derivatives as Potent Inducers of Apoptosis in Human Myeloid Leukemia Cells | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1002/cmdc.200900245 | en_US |
dc.identifier.scopus | 70349774426 | - |
dc.identifier.isi | 000270767900012 | - |
dcterms.isPartOf | Chemmedchem | - |
dcterms.source | Chemmedchem[ISSN 1860-7179],v. 4 (10), p. 1668-1676 | - |
dc.contributor.authorscopusid | 7101729609 | - |
dc.contributor.authorscopusid | 7101681318 | - |
dc.contributor.authorscopusid | 23093335000 | - |
dc.contributor.authorscopusid | 6602771700 | - |
dc.contributor.authorscopusid | 7101636723 | - |
dc.contributor.authorscopusid | 7003810011 | - |
dc.description.lastpage | 1676 | en_US |
dc.identifier.issue | 10 | - |
dc.description.firstpage | 1668 | en_US |
dc.relation.volume | 4 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.wos | WOS:000270767900012 | - |
dc.contributor.daisngid | 32727 | - |
dc.contributor.daisngid | 38403 | - |
dc.contributor.daisngid | 826766 | - |
dc.contributor.daisngid | 428197 | - |
dc.contributor.daisngid | 5695465 | - |
dc.contributor.daisngid | 384944 | - |
dc.identifier.investigatorRID | B-7933-2017 | - |
dc.identifier.investigatorRID | G-9887-2015 | - |
dc.identifier.investigatorRID | K-5125-2014 | - |
dc.identifier.investigatorRID | G-9916-2015 | - |
dc.identifier.investigatorRID | F-3060-2017 | - |
dc.description.numberofpages | 9 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Romagnoli, R | - |
dc.contributor.wosstandard | WOS:Baraldi, PG | - |
dc.contributor.wosstandard | WOS:Cruz-Lopez, O | - |
dc.contributor.wosstandard | WOS:Preti, D | - |
dc.contributor.wosstandard | WOS:Bermejo, J | - |
dc.contributor.wosstandard | WOS:Estevez, F | - |
dc.date.coverdate | Octubre 2009 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 3,232 | - |
dc.description.jcrq | Q1 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.project.principalinvestigator | Estévez Rosas, Francisco Jesús | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0002-9728-2774 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Estévez Rosas, Francisco Jesús | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
16
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
15
checked on Oct 13, 2024
Page view(s)
80
checked on Sep 28, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.